QUIDELORTHO CORP Restructuring Reserve, Current
QUIDELORTHO CORP (QDEL) had Restructuring Reserve, Current of $100.00 thousand as of 2026-06-28, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Restructuring and Related Activities
us-gaap:RestructuringReserveCurrent · last filed 2026-08-07
- 2026-06-28: Restructuring Reserve, Current $100.00K.
- 2026-03-29: Restructuring Reserve, Current $800.00K.
- 2025-12-28: Restructuring Reserve, Current $500.00K.
| Period end | Restructuring Reserve, Current |
|---|---|
| 2026-06-28 | $100.00K 10-Q · filed 2026-08-07 |
| 2026-03-29 | $800.00K 10-Q · filed 2026-05-06 |
| 2025-12-28 | $500.00K 10-K · filed 2026-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |